These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2926043)

  • 1. Ventricular fibrillation in six adults without overt heart disease.
    Lemery R; Brugada P; Della Bella P; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1989 Mar; 13(4):911-6. PubMed ID: 2926043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.
    Lemery R; Brugada P; Bella PD; Dugernier T; van den Dool A; Wellens HJ
    Circulation; 1989 May; 79(5):990-9. PubMed ID: 2713978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation.
    Wever EF; Hauer RN; Oomen A; Peters RH; Bakker PF; Robles de Medina EO
    Circulation; 1993 Sep; 88(3):1021-9. PubMed ID: 8353864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the prolonged QT syndrome and recurrent ventricular fibrillation with an implantable automatic cardioverter-defibrillator.
    Platia EV; Griffith LS; Watkins L; Mirowski M; Mower MM; Reid PR
    Clin Cardiol; 1985 Sep; 8(9):490-3. PubMed ID: 4042451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Programmed stimulation in patients with malignant ventricular arrhythmias. I: Diagnostic value].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Feb; 9(1):45-51. PubMed ID: 6200414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device.
    Winters SL; Cohen M; Greenberg S; Stein B; Curwin J; Pe E; Gomes JA
    J Am Coll Cardiol; 1991 Oct; 18(4):937-43. PubMed ID: 1894867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
    Marchlinski FE; Flores BT; Buxton AE; Hargrove WC; Addonizio VP; Stephenson LW; Harken AH; Doherty JU; Grogan EW; Josephson ME
    Ann Intern Med; 1986 Apr; 104(4):481-8. PubMed ID: 3954276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Programmed ventricular stimulation in detecting malignant ventricular arrhythmia following myocardial infarct].
    Klein H
    Internist (Berl); 1987 Mar; 28(3):151-8. PubMed ID: 3294721
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.
    Belhassen B; Shapira I; Shoshani D; Paredes A; Miller H; Laniado S
    Circulation; 1987 Apr; 75(4):809-16. PubMed ID: 3829343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.
    Manolis AS; Tan-DeGuzman W; Lee MA; Rastegar H; Haffajee CI; Huang SK; Estes NA
    Am Heart J; 1989 Sep; 118(3):445-50. PubMed ID: 2773768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
    Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses.
    Hammill SC; Sugrue DD; Gersh BJ; Porter CB; Osborn MJ; Wood DL; Holmes DR
    Mayo Clin Proc; 1986 Jun; 61(6):478-503. PubMed ID: 3520168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
    Kuck KH; Kunze KP; Schlüter M; Nienaber CA; Costard A
    Eur Heart J; 1988 Feb; 9(2):177-85. PubMed ID: 3280318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.